nodes	percent_of_prediction	percent_of_DWPC	metapath
Verteporfin—Extravasation—Carboplatin—bone cancer	0.0455	0.0455	CcSEcCtD
Verteporfin—Injection site haemorrhage—Epirubicin—bone cancer	0.0222	0.0222	CcSEcCtD
Verteporfin—Sunburn—Methotrexate—bone cancer	0.0212	0.0212	CcSEcCtD
Verteporfin—Injection site haemorrhage—Doxorubicin—bone cancer	0.0206	0.0206	CcSEcCtD
Verteporfin—Injection site inflammation—Epirubicin—bone cancer	0.0179	0.0179	CcSEcCtD
Verteporfin—Injection site inflammation—Doxorubicin—bone cancer	0.0166	0.0166	CcSEcCtD
Verteporfin—Prostatic disorder—Epirubicin—bone cancer	0.0141	0.0141	CcSEcCtD
Verteporfin—Raised liver function tests—Methotrexate—bone cancer	0.0138	0.0138	CcSEcCtD
Verteporfin—Extravasation—Cisplatin—bone cancer	0.0134	0.0134	CcSEcCtD
Verteporfin—Prostatic disorder—Doxorubicin—bone cancer	0.013	0.013	CcSEcCtD
Verteporfin—Hearing impaired—Cisplatin—bone cancer	0.0122	0.0122	CcSEcCtD
Verteporfin—Peripheral vascular disorder—Epirubicin—bone cancer	0.0122	0.0122	CcSEcCtD
Verteporfin—Pain—Carboplatin—bone cancer	0.0121	0.0121	CcSEcCtD
Verteporfin—Peripheral vascular disorder—Doxorubicin—bone cancer	0.0113	0.0113	CcSEcCtD
Verteporfin—Body temperature increased—Carboplatin—bone cancer	0.0112	0.0112	CcSEcCtD
Verteporfin—Myasthenia—Epirubicin—bone cancer	0.00952	0.00952	CcSEcCtD
Verteporfin—Myasthenia—Doxorubicin—bone cancer	0.00881	0.00881	CcSEcCtD
Verteporfin—Blister—Epirubicin—bone cancer	0.0083	0.0083	CcSEcCtD
Verteporfin—Albuminuria—Epirubicin—bone cancer	0.00801	0.00801	CcSEcCtD
Verteporfin—Blood creatinine increased—Cisplatin—bone cancer	0.00792	0.00792	CcSEcCtD
Verteporfin—Scotoma—Epirubicin—bone cancer	0.00788	0.00788	CcSEcCtD
Verteporfin—Blister—Doxorubicin—bone cancer	0.00768	0.00768	CcSEcCtD
Verteporfin—Hyperaesthesia—Epirubicin—bone cancer	0.00762	0.00762	CcSEcCtD
Verteporfin—Albuminuria—Doxorubicin—bone cancer	0.00742	0.00742	CcSEcCtD
Verteporfin—Injection site pain—Epirubicin—bone cancer	0.00733	0.00733	CcSEcCtD
Verteporfin—Extravasation—Methotrexate—bone cancer	0.00733	0.00733	CcSEcCtD
Verteporfin—Scotoma—Doxorubicin—bone cancer	0.00729	0.00729	CcSEcCtD
Verteporfin—Hyperaesthesia—Doxorubicin—bone cancer	0.00705	0.00705	CcSEcCtD
Verteporfin—Extravasation—Epirubicin—bone cancer	0.00686	0.00686	CcSEcCtD
Verteporfin—Injection site pain—Doxorubicin—bone cancer	0.00678	0.00678	CcSEcCtD
Verteporfin—Inflammation—Methotrexate—bone cancer	0.00659	0.00659	CcSEcCtD
Verteporfin—Arthropathy—Epirubicin—bone cancer	0.00658	0.00658	CcSEcCtD
Verteporfin—Acute coronary syndrome—Cisplatin—bone cancer	0.00642	0.00642	CcSEcCtD
Verteporfin—Myocardial infarction—Cisplatin—bone cancer	0.00639	0.00639	CcSEcCtD
Verteporfin—Extravasation—Doxorubicin—bone cancer	0.00635	0.00635	CcSEcCtD
Verteporfin—Conjunctivitis—Cisplatin—bone cancer	0.00634	0.00634	CcSEcCtD
Verteporfin—Creatinine increased—Epirubicin—bone cancer	0.00629	0.00629	CcSEcCtD
Verteporfin—Inflammation—Epirubicin—bone cancer	0.00617	0.00617	CcSEcCtD
Verteporfin—Arthropathy—Doxorubicin—bone cancer	0.00609	0.00609	CcSEcCtD
Verteporfin—Musculoskeletal pain—Epirubicin—bone cancer	0.00606	0.00606	CcSEcCtD
Verteporfin—Injection site reaction—Epirubicin—bone cancer	0.00595	0.00595	CcSEcCtD
Verteporfin—Creatinine increased—Doxorubicin—bone cancer	0.00582	0.00582	CcSEcCtD
Verteporfin—Inflammation—Doxorubicin—bone cancer	0.00571	0.00571	CcSEcCtD
Verteporfin—Visual impairment—Cisplatin—bone cancer	0.00564	0.00564	CcSEcCtD
Verteporfin—Musculoskeletal pain—Doxorubicin—bone cancer	0.0056	0.0056	CcSEcCtD
Verteporfin—Dry eye—Epirubicin—bone cancer	0.00553	0.00553	CcSEcCtD
Verteporfin—Injection site reaction—Doxorubicin—bone cancer	0.0055	0.0055	CcSEcCtD
Verteporfin—Eye disorder—Cisplatin—bone cancer	0.00547	0.00547	CcSEcCtD
Verteporfin—Flushing—Cisplatin—bone cancer	0.00543	0.00543	CcSEcCtD
Verteporfin—Cardiac disorder—Cisplatin—bone cancer	0.00543	0.00543	CcSEcCtD
Verteporfin—Photosensitivity—Methotrexate—bone cancer	0.00529	0.00529	CcSEcCtD
Verteporfin—Immune system disorder—Cisplatin—bone cancer	0.00528	0.00528	CcSEcCtD
Verteporfin—Dry eye—Doxorubicin—bone cancer	0.00511	0.00511	CcSEcCtD
Verteporfin—Malnutrition—Cisplatin—bone cancer	0.00509	0.00509	CcSEcCtD
Verteporfin—Photosensitivity—Epirubicin—bone cancer	0.00495	0.00495	CcSEcCtD
Verteporfin—Visual disturbance—Methotrexate—bone cancer	0.0049	0.0049	CcSEcCtD
Verteporfin—Eczema—Epirubicin—bone cancer	0.00483	0.00483	CcSEcCtD
Verteporfin—Vision blurred—Cisplatin—bone cancer	0.0048	0.0048	CcSEcCtD
Verteporfin—Ill-defined disorder—Cisplatin—bone cancer	0.00473	0.00473	CcSEcCtD
Verteporfin—Anaemia—Cisplatin—bone cancer	0.00471	0.00471	CcSEcCtD
Verteporfin—Osteoarthritis—Methotrexate—bone cancer	0.00464	0.00464	CcSEcCtD
Verteporfin—Malaise—Cisplatin—bone cancer	0.00459	0.00459	CcSEcCtD
Verteporfin—Photosensitivity—Doxorubicin—bone cancer	0.00458	0.00458	CcSEcCtD
Verteporfin—Dermatitis bullous—Epirubicin—bone cancer	0.00454	0.00454	CcSEcCtD
Verteporfin—Eczema—Doxorubicin—bone cancer	0.00447	0.00447	CcSEcCtD
Verteporfin—Diplopia—Epirubicin—bone cancer	0.00434	0.00434	CcSEcCtD
Verteporfin—Osteoarthritis—Epirubicin—bone cancer	0.00434	0.00434	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.00431	0.00431	CcSEcCtD
Verteporfin—Liver function test abnormal—Methotrexate—bone cancer	0.00428	0.00428	CcSEcCtD
Verteporfin—Discomfort—Cisplatin—bone cancer	0.00428	0.00428	CcSEcCtD
Verteporfin—Dermatitis bullous—Doxorubicin—bone cancer	0.0042	0.0042	CcSEcCtD
Verteporfin—Oedema—Cisplatin—bone cancer	0.00416	0.00416	CcSEcCtD
Verteporfin—Nervous system disorder—Cisplatin—bone cancer	0.00408	0.00408	CcSEcCtD
Verteporfin—Blood creatinine increased—Epirubicin—bone cancer	0.00407	0.00407	CcSEcCtD
Verteporfin—Skin disorder—Cisplatin—bone cancer	0.00404	0.00404	CcSEcCtD
Verteporfin—Diplopia—Doxorubicin—bone cancer	0.00402	0.00402	CcSEcCtD
Verteporfin—Osteoarthritis—Doxorubicin—bone cancer	0.00402	0.00402	CcSEcCtD
Verteporfin—Hyperhidrosis—Cisplatin—bone cancer	0.00402	0.00402	CcSEcCtD
Verteporfin—Liver function test abnormal—Epirubicin—bone cancer	0.00401	0.00401	CcSEcCtD
Verteporfin—Muscular weakness—Epirubicin—bone cancer	0.00383	0.00383	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Cisplatin—bone cancer	0.00379	0.00379	CcSEcCtD
Verteporfin—Blood creatinine increased—Doxorubicin—bone cancer	0.00376	0.00376	CcSEcCtD
Verteporfin—Influenza—Epirubicin—bone cancer	0.00375	0.00375	CcSEcCtD
Verteporfin—Liver function test abnormal—Doxorubicin—bone cancer	0.00371	0.00371	CcSEcCtD
Verteporfin—Dyspnoea—Cisplatin—bone cancer	0.00371	0.00371	CcSEcCtD
Verteporfin—Photosensitivity reaction—Methotrexate—bone cancer	0.00366	0.00366	CcSEcCtD
Verteporfin—Pneumonia—Methotrexate—bone cancer	0.0036	0.0036	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Cisplatin—bone cancer	0.00359	0.00359	CcSEcCtD
Verteporfin—Pain—Cisplatin—bone cancer	0.00355	0.00355	CcSEcCtD
Verteporfin—Muscular weakness—Doxorubicin—bone cancer	0.00354	0.00354	CcSEcCtD
Verteporfin—Conjunctivitis—Methotrexate—bone cancer	0.00348	0.00348	CcSEcCtD
Verteporfin—Influenza—Doxorubicin—bone cancer	0.00347	0.00347	CcSEcCtD
Verteporfin—Sweating—Methotrexate—bone cancer	0.00343	0.00343	CcSEcCtD
Verteporfin—Photosensitivity reaction—Epirubicin—bone cancer	0.00343	0.00343	CcSEcCtD
Verteporfin—Feeling abnormal—Cisplatin—bone cancer	0.00343	0.00343	CcSEcCtD
Verteporfin—Pneumonia—Epirubicin—bone cancer	0.00337	0.00337	CcSEcCtD
Verteporfin—Body temperature increased—Cisplatin—bone cancer	0.00329	0.00329	CcSEcCtD
Verteporfin—Conjunctivitis—Epirubicin—bone cancer	0.00325	0.00325	CcSEcCtD
Verteporfin—Haemoglobin—Methotrexate—bone cancer	0.00323	0.00323	CcSEcCtD
Verteporfin—Haemorrhage—Methotrexate—bone cancer	0.00321	0.00321	CcSEcCtD
Verteporfin—Sweating—Epirubicin—bone cancer	0.00321	0.00321	CcSEcCtD
Verteporfin—Pharyngitis—Methotrexate—bone cancer	0.00319	0.00319	CcSEcCtD
Verteporfin—Photosensitivity reaction—Doxorubicin—bone cancer	0.00317	0.00317	CcSEcCtD
Verteporfin—Pneumonia—Doxorubicin—bone cancer	0.00311	0.00311	CcSEcCtD
Verteporfin—Visual impairment—Methotrexate—bone cancer	0.00309	0.00309	CcSEcCtD
Verteporfin—Hypersensitivity—Cisplatin—bone cancer	0.00306	0.00306	CcSEcCtD
Verteporfin—Haemoglobin—Epirubicin—bone cancer	0.00302	0.00302	CcSEcCtD
Verteporfin—Conjunctivitis—Doxorubicin—bone cancer	0.00301	0.00301	CcSEcCtD
Verteporfin—Haemorrhage—Epirubicin—bone cancer	0.003	0.003	CcSEcCtD
Verteporfin—Eye disorder—Methotrexate—bone cancer	0.003	0.003	CcSEcCtD
Verteporfin—Hypoaesthesia—Epirubicin—bone cancer	0.00299	0.00299	CcSEcCtD
Verteporfin—Asthenia—Cisplatin—bone cancer	0.00298	0.00298	CcSEcCtD
Verteporfin—Pharyngitis—Epirubicin—bone cancer	0.00298	0.00298	CcSEcCtD
Verteporfin—Cardiac disorder—Methotrexate—bone cancer	0.00298	0.00298	CcSEcCtD
Verteporfin—Sweating—Doxorubicin—bone cancer	0.00297	0.00297	CcSEcCtD
Verteporfin—Angiopathy—Methotrexate—bone cancer	0.00291	0.00291	CcSEcCtD
Verteporfin—Immune system disorder—Methotrexate—bone cancer	0.0029	0.0029	CcSEcCtD
Verteporfin—Visual impairment—Epirubicin—bone cancer	0.0029	0.0029	CcSEcCtD
Verteporfin—Eye disorder—Epirubicin—bone cancer	0.00281	0.00281	CcSEcCtD
Verteporfin—Malnutrition—Methotrexate—bone cancer	0.00279	0.00279	CcSEcCtD
Verteporfin—Haemoglobin—Doxorubicin—bone cancer	0.00279	0.00279	CcSEcCtD
Verteporfin—Flushing—Epirubicin—bone cancer	0.00279	0.00279	CcSEcCtD
Verteporfin—Cardiac disorder—Epirubicin—bone cancer	0.00279	0.00279	CcSEcCtD
Verteporfin—Haemorrhage—Doxorubicin—bone cancer	0.00278	0.00278	CcSEcCtD
Verteporfin—Hypoaesthesia—Doxorubicin—bone cancer	0.00277	0.00277	CcSEcCtD
Verteporfin—Pharyngitis—Doxorubicin—bone cancer	0.00276	0.00276	CcSEcCtD
Verteporfin—Angiopathy—Epirubicin—bone cancer	0.00273	0.00273	CcSEcCtD
Verteporfin—Immune system disorder—Epirubicin—bone cancer	0.00271	0.00271	CcSEcCtD
Verteporfin—Back pain—Methotrexate—bone cancer	0.0027	0.0027	CcSEcCtD
Verteporfin—Visual impairment—Doxorubicin—bone cancer	0.00268	0.00268	CcSEcCtD
Verteporfin—Vision blurred—Methotrexate—bone cancer	0.00263	0.00263	CcSEcCtD
Verteporfin—Rash—Cisplatin—bone cancer	0.00262	0.00262	CcSEcCtD
Verteporfin—Dermatitis—Cisplatin—bone cancer	0.00262	0.00262	CcSEcCtD
Verteporfin—Malnutrition—Epirubicin—bone cancer	0.00262	0.00262	CcSEcCtD
Verteporfin—Eye disorder—Doxorubicin—bone cancer	0.0026	0.0026	CcSEcCtD
Verteporfin—Ill-defined disorder—Methotrexate—bone cancer	0.00259	0.00259	CcSEcCtD
Verteporfin—Anaemia—Methotrexate—bone cancer	0.00258	0.00258	CcSEcCtD
Verteporfin—Flushing—Doxorubicin—bone cancer	0.00258	0.00258	CcSEcCtD
Verteporfin—Cardiac disorder—Doxorubicin—bone cancer	0.00258	0.00258	CcSEcCtD
Verteporfin—Back pain—Epirubicin—bone cancer	0.00253	0.00253	CcSEcCtD
Verteporfin—Angiopathy—Doxorubicin—bone cancer	0.00252	0.00252	CcSEcCtD
Verteporfin—Malaise—Methotrexate—bone cancer	0.00252	0.00252	CcSEcCtD
Verteporfin—Immune system disorder—Doxorubicin—bone cancer	0.00251	0.00251	CcSEcCtD
Verteporfin—Vertigo—Methotrexate—bone cancer	0.00251	0.00251	CcSEcCtD
Verteporfin—Nausea—Cisplatin—bone cancer	0.00247	0.00247	CcSEcCtD
Verteporfin—Vision blurred—Epirubicin—bone cancer	0.00246	0.00246	CcSEcCtD
Verteporfin—Cough—Methotrexate—bone cancer	0.00244	0.00244	CcSEcCtD
Verteporfin—Ill-defined disorder—Epirubicin—bone cancer	0.00243	0.00243	CcSEcCtD
Verteporfin—Malnutrition—Doxorubicin—bone cancer	0.00242	0.00242	CcSEcCtD
Verteporfin—Anaemia—Epirubicin—bone cancer	0.00242	0.00242	CcSEcCtD
Verteporfin—Arthralgia—Methotrexate—bone cancer	0.00238	0.00238	CcSEcCtD
Verteporfin—Chest pain—Methotrexate—bone cancer	0.00238	0.00238	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.00236	0.00236	CcSEcCtD
Verteporfin—Malaise—Epirubicin—bone cancer	0.00236	0.00236	CcSEcCtD
Verteporfin—Discomfort—Methotrexate—bone cancer	0.00235	0.00235	CcSEcCtD
Verteporfin—Vertigo—Epirubicin—bone cancer	0.00235	0.00235	CcSEcCtD
Verteporfin—Syncope—Epirubicin—bone cancer	0.00235	0.00235	CcSEcCtD
Verteporfin—Back pain—Doxorubicin—bone cancer	0.00234	0.00234	CcSEcCtD
Verteporfin—Loss of consciousness—Epirubicin—bone cancer	0.0023	0.0023	CcSEcCtD
Verteporfin—Cough—Epirubicin—bone cancer	0.00228	0.00228	CcSEcCtD
Verteporfin—Vision blurred—Doxorubicin—bone cancer	0.00228	0.00228	CcSEcCtD
Verteporfin—Hypertension—Epirubicin—bone cancer	0.00226	0.00226	CcSEcCtD
Verteporfin—Ill-defined disorder—Doxorubicin—bone cancer	0.00225	0.00225	CcSEcCtD
Verteporfin—Nervous system disorder—Methotrexate—bone cancer	0.00224	0.00224	CcSEcCtD
Verteporfin—Anaemia—Doxorubicin—bone cancer	0.00224	0.00224	CcSEcCtD
Verteporfin—Arthralgia—Epirubicin—bone cancer	0.00223	0.00223	CcSEcCtD
Verteporfin—Chest pain—Epirubicin—bone cancer	0.00223	0.00223	CcSEcCtD
Verteporfin—Skin disorder—Methotrexate—bone cancer	0.00222	0.00222	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.00221	0.00221	CcSEcCtD
Verteporfin—Hyperhidrosis—Methotrexate—bone cancer	0.00221	0.00221	CcSEcCtD
Verteporfin—Discomfort—Epirubicin—bone cancer	0.0022	0.0022	CcSEcCtD
Verteporfin—Malaise—Doxorubicin—bone cancer	0.00218	0.00218	CcSEcCtD
Verteporfin—Vertigo—Doxorubicin—bone cancer	0.00217	0.00217	CcSEcCtD
Verteporfin—Syncope—Doxorubicin—bone cancer	0.00217	0.00217	CcSEcCtD
Verteporfin—Oedema—Epirubicin—bone cancer	0.00213	0.00213	CcSEcCtD
Verteporfin—Loss of consciousness—Doxorubicin—bone cancer	0.00213	0.00213	CcSEcCtD
Verteporfin—Cough—Doxorubicin—bone cancer	0.00211	0.00211	CcSEcCtD
Verteporfin—Shock—Epirubicin—bone cancer	0.0021	0.0021	CcSEcCtD
Verteporfin—Nervous system disorder—Epirubicin—bone cancer	0.00209	0.00209	CcSEcCtD
Verteporfin—Hypertension—Doxorubicin—bone cancer	0.00209	0.00209	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Methotrexate—bone cancer	0.00208	0.00208	CcSEcCtD
Verteporfin—Skin disorder—Epirubicin—bone cancer	0.00207	0.00207	CcSEcCtD
Verteporfin—Hyperhidrosis—Epirubicin—bone cancer	0.00206	0.00206	CcSEcCtD
Verteporfin—Arthralgia—Doxorubicin—bone cancer	0.00206	0.00206	CcSEcCtD
Verteporfin—Chest pain—Doxorubicin—bone cancer	0.00206	0.00206	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.00205	0.00205	CcSEcCtD
Verteporfin—Discomfort—Doxorubicin—bone cancer	0.00204	0.00204	CcSEcCtD
Verteporfin—Dyspnoea—Methotrexate—bone cancer	0.00203	0.00203	CcSEcCtD
Verteporfin—Oedema—Doxorubicin—bone cancer	0.00198	0.00198	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Methotrexate—bone cancer	0.00197	0.00197	CcSEcCtD
Verteporfin—Pain—Methotrexate—bone cancer	0.00195	0.00195	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Epirubicin—bone cancer	0.00194	0.00194	CcSEcCtD
Verteporfin—Shock—Doxorubicin—bone cancer	0.00194	0.00194	CcSEcCtD
Verteporfin—Nervous system disorder—Doxorubicin—bone cancer	0.00194	0.00194	CcSEcCtD
Verteporfin—Skin disorder—Doxorubicin—bone cancer	0.00192	0.00192	CcSEcCtD
Verteporfin—Hyperhidrosis—Doxorubicin—bone cancer	0.00191	0.00191	CcSEcCtD
Verteporfin—Dyspnoea—Epirubicin—bone cancer	0.0019	0.0019	CcSEcCtD
Verteporfin—Feeling abnormal—Methotrexate—bone cancer	0.00188	0.00188	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Epirubicin—bone cancer	0.00184	0.00184	CcSEcCtD
Verteporfin—Pain—Epirubicin—bone cancer	0.00183	0.00183	CcSEcCtD
Verteporfin—Constipation—Epirubicin—bone cancer	0.00183	0.00183	CcSEcCtD
Verteporfin—Urticaria—Methotrexate—bone cancer	0.00181	0.00181	CcSEcCtD
Verteporfin—Body temperature increased—Methotrexate—bone cancer	0.0018	0.0018	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.0018	0.0018	CcSEcCtD
Verteporfin—Dyspnoea—Doxorubicin—bone cancer	0.00176	0.00176	CcSEcCtD
Verteporfin—Feeling abnormal—Epirubicin—bone cancer	0.00176	0.00176	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Doxorubicin—bone cancer	0.00171	0.00171	CcSEcCtD
Verteporfin—Urticaria—Epirubicin—bone cancer	0.0017	0.0017	CcSEcCtD
Verteporfin—Pain—Doxorubicin—bone cancer	0.00169	0.00169	CcSEcCtD
Verteporfin—Constipation—Doxorubicin—bone cancer	0.00169	0.00169	CcSEcCtD
Verteporfin—Body temperature increased—Epirubicin—bone cancer	0.00169	0.00169	CcSEcCtD
Verteporfin—Hypersensitivity—Methotrexate—bone cancer	0.00168	0.00168	CcSEcCtD
Verteporfin—Asthenia—Methotrexate—bone cancer	0.00164	0.00164	CcSEcCtD
Verteporfin—Feeling abnormal—Doxorubicin—bone cancer	0.00163	0.00163	CcSEcCtD
Verteporfin—Pruritus—Methotrexate—bone cancer	0.00161	0.00161	CcSEcCtD
Verteporfin—Hypersensitivity—Epirubicin—bone cancer	0.00157	0.00157	CcSEcCtD
Verteporfin—Urticaria—Doxorubicin—bone cancer	0.00157	0.00157	CcSEcCtD
Verteporfin—Body temperature increased—Doxorubicin—bone cancer	0.00156	0.00156	CcSEcCtD
Verteporfin—Asthenia—Epirubicin—bone cancer	0.00153	0.00153	CcSEcCtD
Verteporfin—Pruritus—Epirubicin—bone cancer	0.00151	0.00151	CcSEcCtD
Verteporfin—Dizziness—Methotrexate—bone cancer	0.00151	0.00151	CcSEcCtD
Verteporfin—Hypersensitivity—Doxorubicin—bone cancer	0.00146	0.00146	CcSEcCtD
Verteporfin—Rash—Methotrexate—bone cancer	0.00144	0.00144	CcSEcCtD
Verteporfin—Dermatitis—Methotrexate—bone cancer	0.00144	0.00144	CcSEcCtD
Verteporfin—Headache—Methotrexate—bone cancer	0.00143	0.00143	CcSEcCtD
Verteporfin—Asthenia—Doxorubicin—bone cancer	0.00142	0.00142	CcSEcCtD
Verteporfin—Dizziness—Epirubicin—bone cancer	0.00141	0.00141	CcSEcCtD
Verteporfin—Pruritus—Doxorubicin—bone cancer	0.0014	0.0014	CcSEcCtD
Verteporfin—Nausea—Methotrexate—bone cancer	0.00135	0.00135	CcSEcCtD
Verteporfin—Rash—Epirubicin—bone cancer	0.00135	0.00135	CcSEcCtD
Verteporfin—Dermatitis—Epirubicin—bone cancer	0.00134	0.00134	CcSEcCtD
Verteporfin—Headache—Epirubicin—bone cancer	0.00134	0.00134	CcSEcCtD
Verteporfin—Dizziness—Doxorubicin—bone cancer	0.00131	0.00131	CcSEcCtD
Verteporfin—Nausea—Epirubicin—bone cancer	0.00127	0.00127	CcSEcCtD
Verteporfin—Rash—Doxorubicin—bone cancer	0.00125	0.00125	CcSEcCtD
Verteporfin—Dermatitis—Doxorubicin—bone cancer	0.00124	0.00124	CcSEcCtD
Verteporfin—Headache—Doxorubicin—bone cancer	0.00124	0.00124	CcSEcCtD
Verteporfin—Nausea—Doxorubicin—bone cancer	0.00117	0.00117	CcSEcCtD
